CN111544578A - Multi-functional cold compress eye of chinese mugwort pastes - Google Patents
Multi-functional cold compress eye of chinese mugwort pastes Download PDFInfo
- Publication number
- CN111544578A CN111544578A CN202010509106.XA CN202010509106A CN111544578A CN 111544578 A CN111544578 A CN 111544578A CN 202010509106 A CN202010509106 A CN 202010509106A CN 111544578 A CN111544578 A CN 111544578A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- eye
- skin care
- essential oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000010894 Artemisia argyi Nutrition 0.000 title claims abstract description 24
- 244000030166 artemisia Species 0.000 title claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 37
- 239000000341 volatile oil Substances 0.000 claims abstract description 20
- 239000011259 mixed solution Substances 0.000 claims abstract description 16
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 11
- 102000008186 Collagen Human genes 0.000 claims abstract description 11
- 108010035532 Collagen Proteins 0.000 claims abstract description 11
- 229920001436 collagen Polymers 0.000 claims abstract description 11
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 10
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 241000208680 Hamamelis mollis Species 0.000 claims abstract description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 10
- 241000241413 Propolis Species 0.000 claims abstract description 10
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 10
- 241000220317 Rosa Species 0.000 claims abstract description 10
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 10
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 10
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 10
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 10
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 10
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 10
- 235000011477 liquorice Nutrition 0.000 claims abstract description 10
- 229940105902 mint extract Drugs 0.000 claims abstract description 10
- 229920001184 polypeptide Polymers 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 10
- 229940069949 propolis Drugs 0.000 claims abstract description 10
- 229940118846 witch hazel Drugs 0.000 claims abstract description 10
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 235000008113 selfheal Nutrition 0.000 claims abstract description 8
- 230000001954 sterilising effect Effects 0.000 claims abstract description 8
- 239000004744 fabric Substances 0.000 claims abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 238000004806 packaging method and process Methods 0.000 claims abstract description 6
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 241000196324 Embryophyta Species 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 6
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 4
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000005272 common selfheal Nutrition 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 239000012510 hollow fiber Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 206010013774 Dry eye Diseases 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 208000031513 cyst Diseases 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 description 5
- 208000003464 asthenopia Diseases 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- ZAVJTSLIGAGALR-UHFFFAOYSA-N 2-(2,2,2-trifluoroacetyl)cyclooctan-1-one Chemical compound FC(F)(F)C(=O)C1CCCCCCC1=O ZAVJTSLIGAGALR-UHFFFAOYSA-N 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 208000031973 Conjunctivitis infective Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000029091 Refraction disease Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000004430 ametropia Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000029444 double vision Diseases 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229960002927 hydroxychloroquine sulfate Drugs 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Animal Husbandry (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a multifunctional cold-compress eye patch with Chinese mugwort, which is prepared by soaking a graphene eye patch cloth serving as a carrier in a mixed solution of Chinese medicinal herb skin care extracts, performing ultraviolet sterilization and packaging, wherein the mixed solution of the Chinese medicinal herb skin care extracts comprises the following raw materials in parts by weight: 6 parts of Chinese mugwort extract, 2 parts of selfheal, 2 parts of abalone shell, 2 parts of wild chrysanthemum flower, 2 parts of salvia miltiorrhiza, 2 parts of moutan bark, 4 parts of polypeptide, 2 parts of pearl powder, 2 parts of mint extract, 2 parts of grape essential oil, 2 parts of white poria, 3 parts of propolis, 3 parts of angelica, 4 parts of liquorice, 4 parts of witch hazel, 4 parts of angelica dahurica, 4 parts of rose essential oil and 6 parts of collagen. The eye patch takes the graphene eye patch cloth as a carrier, the eye patch liquid has good permeability and is easy to absorb, and the eye patch liquid not only contains plant components for nourishing skin around eyes, but also contains medicinal components with health care function, recovers the elasticity of skin around eyes, can also have the effects of reducing fat and relieving swelling on fat cysts forming under-eye puffiness, and better improves eye dryness and fatigue.
Description
Technical Field
The invention relates to a multifunctional cold compress eye patch containing Chinese mugwort, and particularly relates to the technical field of Chinese mugwort products.
Background
The resistance of eyes is reduced due to long-term operation of computers or other reasons such as living habits, and ophthalmic diseases such as pinkeye and corneal infiltration are easily infected. The eye patch is a good health-care product for relieving eye problems, the eye patch is more and more popular in pursuit of good things along with the improvement of life quality of people, subcutaneous fat gradually shrinks along with the increase of age, skin becomes thinner, collagen which gives water retention and elasticity to the skin can slowly run off, the elasticity of the skin is poor, the skin of the eye is loose and droops, and lacrimal ducts on the inner side of the lower eyelid can be shown. And ultraviolet radiation in outdoor sports or standing in an air-conditioned room can cause drying phenomenon around eyes and even peeling. Drying around the eyes also tends to produce fine lines. Therefore, people have strong demand for eye patches with anti-wrinkle effect.
In the prior art, some eye patches have a health care effect and can relieve eye fatigue, and some eye patches have an eye skin caring effect, but the eye patches with two effects are less common in the market at present.
Disclosure of Invention
The invention aims to provide a multifunctional cold compress eye patch containing Chinese mugwort, which aims to solve the problems in the background art.
In order to achieve the purpose, the invention provides the following technical scheme: a multifunctional cold compress eye patch containing folium Artemisiae Argyi is prepared by soaking graphene eye patch cloth as carrier in Chinese medicinal material skin care extract mixed solution, performing ultraviolet sterilization, and packaging, wherein the Chinese medicinal material skin care extract mixed solution comprises the following raw materials in parts by weight: 5-8 parts of Chinese mugwort extract, 1-3 parts of selfheal, 1-3 parts of abalone shell, 1-3 parts of wild chrysanthemum flower, 1-3 parts of salvia miltiorrhiza, 1-3 parts of tree peony bark, 3-5 parts of polypeptide, 1-3 parts of pearl powder, 1-3 parts of mint extract, 1-3 parts of grape essential oil, 1-3 parts of white poria, 2-4 parts of propolis, 2-4 parts of angelica, 2-5 parts of liquorice, 1-5 parts of witch hazel, 1-5 parts of angelica dahurica, 3-5 parts of rose essential oil and 3-8 parts of collagen.
Further preferably, the Chinese medicinal material skin care extract mixed solution comprises the following raw materials in parts by weight: 6 parts of Chinese mugwort extract, 2 parts of selfheal, 2 parts of abalone shell, 2 parts of wild chrysanthemum flower, 2 parts of salvia miltiorrhiza, 2 parts of moutan bark, 4 parts of polypeptide, 2 parts of pearl powder, 2 parts of mint extract, 2 parts of grape essential oil, 2 parts of white poria, 3 parts of propolis, 3 parts of angelica, 4 parts of liquorice, 4 parts of witch hazel, 4 parts of angelica dahurica, 4 parts of rose essential oil and 6 parts of collagen.
The preparation method of the Chinese medicinal material skin care extract mixed liquor comprises the following steps: mixing and crushing common selfheal fruit-spike, abalone shell, wild chrysanthemum flower, salvia miltiorrhiza, tree peony bark, white poria, Chinese angelica, liquorice, witch hazel and angelica dahurica according to the weight part of the mixed liquid of the Chinese medicinal skin care extracts, adding a certain amount of distilled water, uniformly stirring, carrying out high-pressure homogenization treatment for 2-3 hours to obtain homogenate, introducing the homogenate into an extraction kettle, extracting for 2-3 hours by using supercritical CO as an extracting agent and beeswax as an entrainer at the extraction temperature of 25-40 ℃, the fluid pressure of 20-40 MPa and the flow rate of 0.10-0.40 ml/min to obtain an extract, filtering the extract by using a hollow fiber filter, mixing the filtered extract with Chinese mugwort extract, polypeptide, pearl powder, a mint extract, grape essential oil, propolis, rose essential oil and collagen, and carrying out high-temperature sterilization to prepare the Chinese mugwort extract.
Compared with the prior art, the invention has the beneficial effects that: the eye patch takes the graphene eye patch cloth as a carrier, the eye patch liquid has good permeability and is easy to absorb, and the eye patch liquid not only contains plant components for nourishing skin around eyes, but also contains medicinal components with health care function, can smooth the appeared pouch, tighten the loose eye skin, recover the elasticity of the skin around the eyes, and also has the functions of reducing fat and relieving swelling for the fat cyst forming the pouch, and can better improve the dryness and fatigue of the eyes.
Drawings
Fig. 1 is a schematic structural view of the eye patch of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1: referring to fig. 1, a multifunctional cold compress eye patch containing Chinese mugwort is prepared by soaking a graphene eye patch as a carrier in a mixed solution of Chinese medicinal herb skin care extracts, performing ultraviolet sterilization, and packaging, wherein the mixed solution of Chinese medicinal herb skin care extracts comprises the following raw materials in parts by weight: 5 parts of Chinese mugwort extract, 1 part of selfheal, 1 part of abalone shell, 1 part of wild chrysanthemum flower, 1 part of salvia miltiorrhiza, 1 part of moutan bark, 3 parts of polypeptide, 1 part of pearl powder, 1 part of mint extract, 1 part of grape essential oil, 1 part of white poria, 2 parts of propolis, 2 parts of angelica, 2 parts of liquorice, 1 part of witch hazel, 1 part of angelica root, 3 parts of rose essential oil and 3 parts of collagen.
Example 2: a multifunctional cold compress eye patch containing folium Artemisiae Argyi is prepared by soaking graphene eye patch cloth as carrier in Chinese medicinal material skin care extract mixed solution, performing ultraviolet sterilization, and packaging, wherein the Chinese medicinal material skin care extract mixed solution comprises the following raw materials in parts by weight: 8 parts of Chinese mugwort extract, 3 parts of selfheal, 3 parts of abalone shell, 3 parts of wild chrysanthemum flower, 3 parts of salvia miltiorrhiza, 3 parts of moutan bark, 5 parts of polypeptide, 3 parts of pearl powder, 3 parts of mint extract, 3 parts of grape essential oil, 3 parts of white poria, 4 parts of propolis, 4 parts of angelica, 5 parts of liquorice, 5 parts of witch hazel, 5 parts of angelica dahurica, 5 parts of rose essential oil and 8 parts of collagen.
Example 3: a multifunctional cold compress eye patch containing folium Artemisiae Argyi is prepared by soaking graphene eye patch cloth as carrier in Chinese medicinal material skin care extract mixed solution, performing ultraviolet sterilization, and packaging, wherein the Chinese medicinal material skin care extract mixed solution comprises the following raw materials in parts by weight: 6 parts of Chinese mugwort extract, 2 parts of selfheal, 2 parts of abalone shell, 2 parts of wild chrysanthemum flower, 2 parts of salvia miltiorrhiza, 2 parts of moutan bark, 4 parts of polypeptide, 2 parts of pearl powder, 2 parts of mint extract, 2 parts of grape essential oil, 2 parts of white poria, 3 parts of propolis, 3 parts of angelica, 4 parts of liquorice, 4 parts of witch hazel, 4 parts of angelica dahurica, 4 parts of rose essential oil and 6 parts of collagen.
The physical and chemical properties of the multi-functional Chinese mugwort cold compress eye patch prepared in example 1 were measured, and the measurement results are shown in table 1;
TABLE 1
| Item | Index mark |
| pH value | 4.0-9.0 |
| Stability against Heat | Keeping at 40 deg.C for 4h, and returning to room temperature for normal use. |
| Stability against cold | Keeping the temperature at (0-5) DEG for 24h, and recovering to room temperature for normal use. |
| Lead/(mg/kg) | ≤ 40 |
| Mercury/(mg/kg) | ≤ 1 |
| Arsenic/(mg/kg) | ≤ 10 |
| Colony count/(CFU/g) | ≤ 500 |
| The total number of the mould and the microzyme/(CFU/g) is less than or equal to 100 | ≤ 100 |
| Fecal coliform bacteria/g | Not detected out |
| Staphylococcus aureus/g | Not detected out |
| Pseudomonas aeruginosa/g | Not detected out |
The method for verifying the improvement effect of the multifunctional cold compress eye mask containing Chinese mugwort on eye diseases;
clinical data: 400 patients with dry eye and asthenopia collected from 2019, 1 month to 2019, 10 months are selected, the age is between 8 and 80 years, and the average age is 45 years. The patients with confirmed diagnosis are divided into 5 groups, namely test groups 1-3, and a control group 1 and a control group 2, wherein 80 patients are present in each group.
The clinical manifestations of the xerophthalmia patient are that the eyes are dry and lacrimation, photophobia, conjunctival congestion, a little secretion, dry and lusterless cornea and cornea, the corneal epithelium is cloudy and turbid, and the symptoms of the asthenopia patient are that the reading time cannot be lasting, the long-time reading is accompanied by headache, drowsiness, double vision and blurred vision, and the eyes are mostly provided with ametropia.
The treatment method comprises the following steps: 80 patients in test groups 1-3 were fitted with eye patches prepared according to examples 1-3 of the present invention around the eye circles daily, one patch each day in the morning and evening, each application time being 30 minutes. The patients in the control groups 1-2 were treated with hydroxychloroquine sulfate tablets daily by oral administration, 200mg each time, 2 times daily. And the anti-fatigue eye drops are dropped once every night, and the treatment lasts for one month.
And (5) judging the treatment effect. The effect is shown: the relevant symptoms and physical signs of the patients are obviously improved, and the examination shows that each observation index is obviously improved. The method has the following advantages: the relevant symptoms and physical signs of the patient are improved to a certain degree, and the improvement of each observation index to a certain degree is displayed through relevant examination. And (4) invalidation: the related symptoms and signs of the Chinese medicinal composition do not have any obvious change.
The statistics of the patients in each group after treatment are shown in Table 2.
TABLE 2
| Experimental group | Show effect | Is effective | Invalidation | The total effective rate% |
| Example 1 | 40 | 35 | 5 | 93.75% |
| Example 2 | 43 | 34 | 3 | 96.25% |
| Example 3 | 44 | 32 | 4 | 95% |
| Comparative example 1 | 35 | 20 | 25 | 68.75% |
| Comparative example 2 | 40 | 13 | 27 | 66.25 |
Therefore, the multifunctional cold compress eye patch containing the Chinese mugwort prepared by the embodiment has a better treatment effect on the patients with eye diseases and asthenopia.
The Chinese mugwort multifunctional cold compress eye patch is used for verifying the elasticity of skin around eyes;
the concrete case is as follows: chuaiji, female, company and clerk, 36 years old, often worked in front of a computer, so the eyes were often dry and tear, and the eye wrinkles were severe, and through the introduction of friends, the eye dryness symptom was relieved after using the mugwort multifunctional cold compress eye patch for one week, the eye wrinkles became light after one month, and the skin around the eyes had elasticity.
The multifunctional cold compress eye patch is characterized by being of certain von, female doctor, age 34, often written in paper all night, high pressure, dark yellow eye periphery, serious black eye circles, obvious wrinkles, red blood streaks on eyes and frequent pain, wherein the symptoms of eye pain disappear after the multifunctional cold compress eye patch is introduced by friends to use the multifunctional cold compress eye patch for 2 weeks, the red blood streaks disappear and are relieved, the wrinkles on eyes become pale after one month, the dark yellow eye periphery is improved, and the skin around the eyes has elasticity.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (4)
1. The multifunctional cold compress eye mask is characterized in that: the cold compress eye patch is prepared by soaking graphene eye patch cloth serving as a carrier in a mixed solution of Chinese medicinal plant skin care extracts, performing ultraviolet sterilization and packaging, wherein the mixed solution of the Chinese medicinal plant skin care extracts comprises the following raw materials in parts by weight: 5-8 parts of Chinese mugwort extract, 1-3 parts of selfheal, 1-3 parts of abalone shell, 1-3 parts of wild chrysanthemum flower, 1-3 parts of salvia miltiorrhiza, 1-3 parts of tree peony bark, 3-5 parts of polypeptide, 1-3 parts of pearl powder, 1-3 parts of mint extract, 1-3 parts of grape essential oil, 1-3 parts of white poria, 2-4 parts of propolis, 2-4 parts of angelica, 2-5 parts of liquorice, 1-5 parts of witch hazel, 1-5 parts of angelica dahurica, 3-5 parts of rose essential oil and 3-8 parts of collagen.
2. The multi-functional cold compress eye of chinese mugwort that claim 1 shows pastes characterized in that: the Chinese medicinal material skin care extract mixed solution comprises the following raw materials in parts by weight: 6 parts of Chinese mugwort extract, 2 parts of selfheal, 2 parts of abalone shell, 2 parts of wild chrysanthemum flower, 2 parts of salvia miltiorrhiza, 2 parts of moutan bark, 4 parts of polypeptide, 2 parts of pearl powder, 2 parts of mint extract, 2 parts of grape essential oil, 2 parts of white poria, 3 parts of propolis, 3 parts of angelica, 4 parts of liquorice, 4 parts of witch hazel, 4 parts of angelica dahurica, 4 parts of rose essential oil and 6 parts of collagen.
3. The multi-functional cold compress eye of chinese mugwort that claim 1 shows pastes characterized in that: the preparation method of the Chinese medicinal material skin care extract mixed solution comprises the following steps: mixing and crushing common selfheal fruit-spike, abalone shell, wild chrysanthemum flower, salvia miltiorrhiza, tree peony bark, white poria, Chinese angelica, liquorice, witch hazel and angelica dahurica according to the weight part of the mixed liquid of the Chinese medicinal skin care extracts, adding a certain amount of distilled water, uniformly stirring, homogenizing at high pressure for 2-3 hours to obtain homogenate, introducing the homogenate into an extraction kettle, extracting by using supercritical CO as an extracting agent and beeswax as an entrainer to obtain an extract, filtering the extract by using a hollow fiber filter, mixing the filtered extract with Chinese mugwort extract, polypeptide, pearl powder, a mint extract, grape essential oil, propolis, rose essential oil and collagen, and sterilizing at high temperature to obtain the skin care extract.
4. The method for preparing the mixed solution of the skin care extracts of the traditional Chinese medicinal materials as claimed in claim 3, is characterized in that: the conditions in the extraction process are as follows: the extraction temperature is 25-40 ℃, the fluid pressure is 20-40 MPa, the flow rate is 0.10-0.40 ml/min, and the extraction lasts 2-3 h.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010509106.XA CN111544578A (en) | 2020-06-07 | 2020-06-07 | Multi-functional cold compress eye of chinese mugwort pastes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010509106.XA CN111544578A (en) | 2020-06-07 | 2020-06-07 | Multi-functional cold compress eye of chinese mugwort pastes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111544578A true CN111544578A (en) | 2020-08-18 |
Family
ID=71997230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010509106.XA Pending CN111544578A (en) | 2020-06-07 | 2020-06-07 | Multi-functional cold compress eye of chinese mugwort pastes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111544578A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112716882A (en) * | 2021-02-18 | 2021-04-30 | 王瑞勤 | Eye mask for recovering vision and fading fine wrinkles around eyes and formula thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106389775A (en) * | 2016-11-28 | 2017-02-15 | 湖北鼎艾科技有限公司 | Crossostephium leaf cold compressing eye mask |
| CN107551031A (en) * | 2017-09-20 | 2018-01-09 | 杜铭 | A kind of Chinese medicine composition for alleviating kopiopia, include its eye sticker and preparation method |
| CN110478122A (en) * | 2019-07-27 | 2019-11-22 | 郑州百消丹药业有限公司 | A kind of pure Chinese medicine eyeshade and preparation method thereof curing mainly visual fatigue |
| CN110917330A (en) * | 2019-10-30 | 2020-03-27 | 通化力神保健品有限公司 | Ginseng small-molecule peptide graphene eye mask and preparation method thereof |
-
2020
- 2020-06-07 CN CN202010509106.XA patent/CN111544578A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106389775A (en) * | 2016-11-28 | 2017-02-15 | 湖北鼎艾科技有限公司 | Crossostephium leaf cold compressing eye mask |
| CN107551031A (en) * | 2017-09-20 | 2018-01-09 | 杜铭 | A kind of Chinese medicine composition for alleviating kopiopia, include its eye sticker and preparation method |
| CN110478122A (en) * | 2019-07-27 | 2019-11-22 | 郑州百消丹药业有限公司 | A kind of pure Chinese medicine eyeshade and preparation method thereof curing mainly visual fatigue |
| CN110917330A (en) * | 2019-10-30 | 2020-03-27 | 通化力神保健品有限公司 | Ginseng small-molecule peptide graphene eye mask and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112716882A (en) * | 2021-02-18 | 2021-04-30 | 王瑞勤 | Eye mask for recovering vision and fading fine wrinkles around eyes and formula thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102698079B (en) | Medicine composition for treating xerophthalmia and preparation method and application thereof | |
| CN100553657C (en) | A kind of Chinese medicine composition of orally taken for curing cataract | |
| CN111973515B (en) | Bacteriostatic restoration plant extraction composition, preparation method and application thereof | |
| CN102357196B (en) | External traditional Chinese medicine composition for treating xerophthalmia and preparation method thereof | |
| CN108208835A (en) | A kind of black, red matrimony vine compound eyeshield oral liquid and preparation method thereof | |
| CN111544578A (en) | Multi-functional cold compress eye of chinese mugwort pastes | |
| CN107753554A (en) | A kind of prepared slices of Chinese crude drugs for eyeshield | |
| CN104547934A (en) | Medicine preparation for treating electric ophthalmia and preparation method thereof | |
| CN109394987A (en) | The composition and preparation method thereof with treatment eye disease containing dimethyl fumarate | |
| CN109865016A (en) | A kind of pharmaceutical composition and its preparation method and application for treating xerophthalmia | |
| CN109512870A (en) | Pharmaceutical composition and its preparation method and application | |
| CN104367832A (en) | Compound dendrobe eye drops for treating xerophthalmia and preparation method thereof | |
| CN105920280A (en) | Compound preparation for treating retinopathy and amblyopia and preparation method of compound preparation | |
| CN1256128C (en) | Eye disease treating medicine | |
| CN107648397B (en) | Traditional Chinese medicine composition for treating liver-kidney yin deficiency and preparation method and application thereof | |
| CN114010591A (en) | Externally-applied traditional Chinese medicine gel paste for treating asthenopia and preparation method thereof | |
| CN113144102A (en) | Novel eye drop for improving eyesight and resisting fatigue | |
| CN113663026A (en) | Traditional Chinese medicine eye-protecting liquid and preparation method thereof | |
| CN102670851B (en) | Selenium-enriched traditional Chinese medicinal herb eye refreshing drops | |
| CN109568486A (en) | The composition and preparation method thereof with treatment ophthalmology disease containing tropsch imatinib | |
| CN105726983A (en) | Compound dendrobium eye drops for treating xerophthalmia and preparation method thereof | |
| CN114569643B (en) | Application of carpesium abrotanoides in treating early-stage chalazion | |
| CN108904707A (en) | A kind of antibacterial type eyedrops and its configuration method | |
| CN1400004A (en) | Chinese medicine preparation for curing chronic conjunctivitis | |
| CN110269895A (en) | A kind of visual rehabilitation Chinese medicine composition containing fresh Chinese medicine and preparation method thereof, preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200818 |